Delivery Order SPE2DB22D2005-SPE2DB24FJRL4

Award Date 8/15/24
Potential Completion Date 9/6/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PROQUAD VIALS, a medical product, with a ceiling value of $8,629.89 and a period of performance through July 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a medical product, with a ceiling value of $2,740.40 and a period of performance through May 27, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,654.33, is for the delivery of PROQUAD VIALS, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is April 16, 2025. The contract was awarded on March 26, 2025, and has no set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a type of pharmaceutical product, with a ceiling value of $8,354.50 and a period of performance through June 5, 2025. The contract is a Firm Fixed Price, Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product. The contract has a ceiling value of $1,687.48 and a period of performance through May 16, 2025. The contract is a firm fixed-price delivery order, which indicates a pre-existing contract vehicle. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a medical product, with a ceiling value of $1,687.48 and a completion date of May 8, 2025. The contract is a firm fixed-price delivery order, which is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, with a ceiling value of $8,437.40 and a period of performance through June 5, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROQUAD VIALS, a type of pharmaceutical product. The contract has a ceiling value of $8,271.65 and a completion date of July 23, 2025. It is a firm-fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of PROQUAD VIALS. The contract has a ceiling value of $13,234.64 and is a Firm Fixed Price, Delivery Order contract. The period of performance extends to June 17, 2025. This contract is not set aside and was awarded on May 27, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a medical product, with a ceiling value of $1,654.33 and a period of performance through February 21, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. The contract is not designated with a set-aside requirement, indicating open competition....
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJRL4
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a ceiling value of $12,564.32 and a period of performance through September 6, 2024. This contract is a Delivery Order, which means it is part of a larger Indefinite Delivery Contract (IDC) vehicle held by AmerisourceBergen with the DLA Troop Support Medical. The IDC has a potential value of up to $999,999,999 through December 2025 and covers a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and delivery orders to supply critical pharmaceutical and medical supplies to various defense and civilian agencies.

Generated 11/14/24, 9:24 AM